Akums Drugs and Pharmaceuticals Limited

rs,

bai – 400 051 To, The Listing Department BSE Limited Rotunda Building, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Disclosure under R

7%

ed their downward trend. While IPM volumes remained muted, our CDMO business saw a volume growth of 7%. We remain committed to improving margins with a superior product mix in coming quarters. Our domes

50 million

a. Additionally, over the next two years, we envisage supplying medicines of aggregate value of USD 50 million from Indian facilities to Zambia. The plant also aims to establish Zambia as a pharma export hub by

INR 1,600 crore

financial position remains healthy with robust cash flows during H1. Our net cash position of over INR 1,600 crore gives us leverage to pursue both organic as well as inorganic growth opportunities. While the perf

10%

performance. H2 also visibility strong. Focus on ramping up utilization API prices fell over 8-10% YoY*, leading to reduced EBITDA, as CMDO is a cost+ operating model Q2 registered -0.5% dip in g

0.5%

ll over 8-10% YoY*, leading to reduced EBITDA, as CMDO is a cost+ operating model Q2 registered -0.5% dip in gross margins, although H1 remains positive at 0.5%. Continued investment in differentiat

51%

h Akums for establishment of a pharmaceutical manufacturing facility in Zambia • Akums will hold 51% stake in the Joint Venture • Akums to also provide its proprietary technology, know-how, and tec

25 million

, know-how, and technical expertise to the JV • Additionally, GRZ to procure medicines worth USD 25 million per annum from Akums for FY27 and FY28 • The business will be done by the subsidiary Akums Heal

45 million

ums Healthcare (Zambia) Private Limited • • • • • The total project cost will be approx. USD 45 million, where Akums will invest 51% and GRZ will invest 49% Investment from Akums will be in the form of

49%

total project cost will be approx. USD 45 million, where Akums will invest 51% and GRZ will invest 49% Investment from Akums will be in the form of both capital and product technology, and the investm

22 million

ca and is part of the Southern African Development Community (SADC) region. • Population of around 22 million and is expected to grow above 40 million by 2050; high literacy rates >80% • Per capita income wa

40 million

elopment Community (SADC) region. • Population of around 22 million and is expected to grow above 40 million by 2050; high literacy rates >80% • Per capita income was at $1,235 in 2024 and is expected to gr